Immunohistochemical Expression of IMP3 in Cutaneous Basal Cell Carcinoma
Background. Insulin-like growth factor-II mRNA-binding protein 3 (IMP3) is an oncofetal protein upregulated in tumor cells during carcinogenesis. It has been linked to adverse clinical outcome in many malignancies. This study was aimed to evaluate an immunohistochemical expression status of IMP3...
Main Author: | Vladimir Bartos |
---|---|
Format: | Article |
Language: | English |
Published: |
Ivano-Frankivsk National Medical University
2022-09-01
|
Series: | Galician Medical Journal |
Subjects: | |
Online Access: | https://ifnmujournal.com/gmj/article/view/1428 |
Similar Items
-
Immunohistochemical Expression of P53 and Ki-67 in Different Histopathological Variants of Basal Cell Carcinoma
by: Rasoul Esmaeili, et al.
Published: (2015-01-01) -
Clinicopathological and immunohistochemical study of recurrent basal cell carcinoma in Egyptian patients
by: Maha Sultan, et al.
Published: (2018-01-01) -
A comprehensive immunohistochemical analysis of IMP2 and IMP3 in 542 cases of ovarian tumors
by: Kristýna Němejcová, et al.
Published: (2023-02-01) -
Cell kinetic markers in cutaneous squamous and basal cell carcinoma of the head and neck
by: Mojgan Alaeddini, et al.
Published: (2022-07-01) -
Basal cell carcinoma of the prostate diagnosed incidentally with holmium laser enucleation of the prostate: How can we detect prior to benign prostatic hyperplasia surgery?
by: Eiichiro Ohara, et al.
Published: (2021-07-01)